Skip 
Navigation Link

1215 South Walnut Ave.
Demopolis, AL 36732 map map 

Access to Care: 1-800-239-2901




1215 South Walnut Ave.
Demopolis, AL 36732
334.289.2410 
334.289.2416 (fax)


powered by centersite dot net
Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Assistance Dogs Bring Big Boost to Deaf PeopleCDC to Toughen COVID Testing for International TravelersOld Spice, Secret Antiperspirants Recalled Due to BenzeneClinical Trials Are Becoming More Diverse, But There's Still Work To DoRural Hospitals' ERs Just as Effective as Urban Ones: StudyKraft Recalls Powdered Drinks Over Metal, Glass ConcernsVials Found in Lab Contained Vaccine, not Smallpox Virus: CDCAdvances in Care, Impact of COVID Highlights of Latest Cardiologists' MeetingAcross America, Black People Have Worse Health OutcomesVials With Smallpox Labels Found at Vaccine Lab in Pennsylvania: CDCWhite House to Spend Billions to Boost COVID Vaccine SupplyAHA News: Health Class May Influence Heart Risk in South AsiansPfizer COVID Pill to Be Made, Sold Cheaply in 95 Poor CountriesFederal Court Backs Stay on COVID Vaccine Mandate for Large BusinessesMore Than 2 Million COVID Home Test Kits Recalled Due to False Positive ResultsIn Canada, Ban on Menthol Cigarettes Had More Smokers QuittingOklahoma Supreme Courts Overturns $465 Million J & J Opioid RulingPandemic Puts 'Outdated' Infection Control Practices Under ScrutinyMillions of Tons of COVID Masks, Gloves Will End Up in OceansSales of Unproven, Unapproved Stem Cell Therapies Are BoomingCourt Temporarily Blocks Biden’s Vaccine Mandate for Big BusinessesU.S. Reopens Borders to Vaccinated Foreign TravelersIt's Time to Replace Your Smoke Alarm BatteriesAHA News: How Doctors Can Help Their Patients Make Heart-Healthy Lifestyle ChangesWhite House Sets Jan. 4 Deadline for Large, Private U.S. Companies to Mandate VaccinesHepatitis B Shots Advised for All U.S. Adults Under 60Supply Chain Issues Bring Shortages of Drugs, Devices to U.S. HospitalsMedicare Could Negotiate Drug Prices Under Democrat ProposalWe've Been Here Before: How Polio Vaccine Rollout Saved Millions of Young LivesAlmost 1 in 3 U.S. Seniors Now Sees at Least 5 Doctors Per YearLanguage Can Make the Difference Between Home, Hospital Care: StudyAttorneys General Warn About Pot Products That Look Like Halloween TreatsCDC Lowers Threshold for Lead Poisoning in Youngest KidsStronger Breast Implant Safety Measures Announced by FDAWalmart Recalls Room Spray for Rare Bacteria That Sickened 4, Killing 2U.S. Gun Violence Rates Jumped 30% During PandemicMandates, Not Recommendations, Work Best to Get Folks Vaccinated: StudyU.S. Has Shared 200 Million Shots With Other CountriesLittle Change Seen in Americans' Use of Mental Health Services During PandemicWomen Doctors Face Higher Levels of Harassment, Frustration: SurveyEPA Plans New Strategy Against PFAS 'Forever Chemicals'State Spending on Poverty Really Pays Off for Kids: StudyState Lotteries Didn't Help Boost Vaccination RatesVaccinated Foreign Travelers Can Enter United States Beginning Nov. 8Despite Pressures of Pandemic, U.S. Nursing School Enrollment ClimbsBiden Administration to Invest $100 Million to Ease Health Worker ShortageFDA Warns Against Using At-Home Dermal Filler 'Pens'Death Threats, Trolling Common for Scientists Who Speak to Media About COVID'Extreme Heat' Days Have Tripled Since 1980s, and More Are ComingAHA News: Are Monolingual Spanish Speakers More at Risk in the Pandemic?
Questions and AnswersVideosLinksBook Reviews
Related Topics

Health Insurance
Healthcare

Pandemic Puts 'Outdated' Infection Control Practices Under Scrutiny

HealthDay News
by By Amy Norton HealthDay Reporter
Updated: Nov 10th 2021

new article illustration

WEDNESDAY, Nov. 10, 2021 (HealthDay News) -- The COVID-19 pandemic has offered some lessons on respiratory disease transmission, and now a new review suggests that hospitals could use those insights to create even smarter infection-control policies.

The review, published Nov. 9 in the Annals of Internal Medicine, suggests that some longstanding infection-control tactics at hospitals are "outdated."

And certain changes, like greater use of N95 masks, might be in order.

Current infection-control measures are based, in part, on a "false simplification" of respiratory virus transmission, said lead review author Dr. Michael Klompas.

The traditional teaching was that most respiratory viruses, like the flu and common cold, are mainly transmitted by respiratory "droplets" -- relatively heavy particles that people expel when they exhale. Droplets fall to the ground within feet of the infected person, and they're adequately blocked by a surgical mask.

But some other viruses, like measles and tuberculosis, have traditionally been labeled "airborne." That means they can be transmitted among people via tiny "aerosol" particles that remain suspended in the air for a longer time, and those particles can accumulate in a poorly ventilated space.

Surgical masks block some of those minute particles, but not all.

That droplet/aerosol premise has helped guide policies at hospitals. For example, N95 masks are generally reserved for procedures considered "aerosol-generating," like inserting a ventilator tube.

But recent research shows the droplet/aerosol divide to be a dubious one, said Klompas, an infectious disease specialist at Brigham and Women's Hospital in Boston.

"Most of what we exhale is aerosol," he said. And in reality, all respiratory viruses can, to some degree, be transmitted by those tiny airborne particles.

Where did the droplet/airborne distinction come from? It was based on observations regarding proximity. Most respiratory viruses, including the flu, are usually passed among people in relatively close contact.

But then there are pathogens like the measles virus, which can also infect people at greater distances: A U.S. measles outbreak in the 1990s, for example, happened at an international sports event held in a domed stadium.

The droplet-borne/airborne categories emerged to explain those differences in viral transmission.

However, Klompas said, it's really other factors that are key -- such as ventilation. Even airborne pathogens rapidly become "diluted" in a well-ventilated area, which lowers the risk of infection. In a pandemic-era study of train passengers, people seated next to someone with an asymptomatic SARS-CoV-2 infection were 10 times as likely to become infected as passengers who were three seats away.

Poor ventilation, though, lowers the protection afforded by distance, Klompas said.

Duration of exposure matters, too, he explained, even in reasonably well-ventilated places. In that same train passenger study, travelers on long journeys were at greater risk of infection than those on fairly short trips.

Plus, there are differences among respiratory viruses themselves that influence transmission, and differences among the people infected. If, for instance, they have a high "viral load" (the amount of virus in their bodies), they are more contagious.

To Klompas and his colleagues, it all means that infection-control policies based on the droplet/airborne premise deserve a review. Some specifics they suggest:

  • Consider using N95 masks in the care of all patients with a respiratory infection, and not only during aerosol-generating procedures. (Recent research, Klompas said, suggests those procedures carry no extra risk.)
  • Allocate airborne-infection isolation rooms for patients with respiratory infections and a high viral load.
  • Review minimum ventilation standards, and consider increasing standards for non-clinical areas of the hospital (outside of patient care areas).

Dr. David Henderson, of the U.S. National Institutes of Health Clinical Center in Bethesda, Md., cowrote an editorial published with the review.

He called it a "great paper" that highlights the point that there is no strict dichotomy between droplet and aerosol.

As for the practical implications, that's more complicated, according to Henderson. He said that surgical masks, along with eye protection, have worked "extraordinarily well" in preventing COVID-19 outbreaks among U.S. health care workers.

What's more, Henderson noted, other respiratory infections that can spread in hospitals have basically disappeared.

It's not clear that N95 masks would have significant added value, according to Henderson. And they would be challenging to wear. "Over an eight-hour shift, you could feel like you're suffocating," he noted.

That's not to say there's no room for improvement. New masking options that offer better filtration, along with wearability, would be welcome, according to Henderson.

At this point, he said a key lesson he's learned from the pandemic is that "source-control masking" -- masking the infected person -- "really works."

The editorial suggests a "reasonable" approach going forward, once seasonal respiratory infections return to their normal patterns: Have "universal" masking in hospitals each fall through spring, when viruses like the flu are highly active.

More information

Harvard Medical School has more on curbing the spread of COVID-19.

SOURCES: Michael Klompas, MD, MPH, infectious disease specialist, hospital epidemiologist, Brigham and Women's Hospital, Boston; David K. Henderson, MD, Hospital Epidemiology Service, Clinical Center, U.S. National Institutes of Health, Bethesda, Md.; Annals of Internal Medicine, Nov. 9, 2021, online